Young Park, based in South Korea, is currently a CEO of Helixmith USA at Helixmith, bringing experience from previous roles at Helixmith, Vivozon, Aprogen and KoNECT (Korea National Enterprise for Clinical Trials). Young Park holds a Certificate in Clinical Pharmacology @ 서울대학교 (Seoul National University). With a robust skill set that includes Oncology, Pharmaceutical Industry, GCP, Clinical Trials, Pharmacovigilance and more, Young Park contributes valuable insights to the industry. Young Park has 1 email on RocketReach.